Position in AVIR
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$69,168
-$10,859 QoQ
Shares Held
14,875
0.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#80
of 124 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RFG Advisory, LLC holds $11,845,532 across 11 Biotechnology names. AVIR ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
142,790 | $5,570,237 | |
| 2 | 85,989 | $2,702,634 | |||
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
19,613 | $1,535,109 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,989 | $987,995 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
789 | $491,973 | |
| 6 | INCY |
Incyte Corp
|
2,120 | $240,323 | |
| 7 | PRQR |
ProQR Therapeutics N.V.
|
64,000 | $119,040 | |
| 8 | ABVX |
Abivax S.A.
|
643 | $85,686 |
All Filings in AVIR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,168 | 14,875 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $80,027 | 14,875 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $53,103 | 14,875 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||